Intelence

Active Ingredient(s): Etravirine
FDA Approved: * January 18, 2008
Pharm Company: * TIBOTEC
Category: HIV / AIDS

Etravirine (ETR,[1] brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine.[2] Etravirine is marketed by Janssen, a subsidiary of Johnson & Johnson. In January 2008, the Food and Drug Administration approved its use for pati... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Intelence TMC125;100
Intelence 100 mg Oral Tablet
NDC: 59676-570
Labeler:
Janssen Products Lp
Intelence T200
Intelence 200 mg Oral Tablet
NDC: 59676-571
Labeler:
Janssen Products Lp
Intelence TMC125;100
Intelence 100 mg Oral Tablet
NDC: 24236-679
Labeler:
Remedyrepack Inc.
Intelence TMC125;100
Intelence 100 mg Oral Tablet
NDC: 53808-0787
Labeler:
State of Florida Doh Central Pharmacy
Intelence TMC125;100
Intelence 100 mg Oral Tablet
NDC: 54569-6102
Labeler:
A-s Medication Solutions
Intelence T200
Intelence 200 mg Oral Tablet
NDC: 54569-6230
Labeler:
A-s Medication Solutions
Intelence TMC125;100
Intelence 100 mg Oral Tablet
NDC: 54868-5864
Labeler:
Physicians Total Care, Inc.
Intelence T200
Intelence 200 mg Oral Tablet
NDC: 54868-6368
Labeler:
Physicians Total Care, Inc.
Intelence 25 mg Oral Tablet
NDC: 59676-572
Labeler:
Janssen Products Lp